News / Toolbox
Careful mouse tests could forecast fate of Angelman drugs
/
A new protocol enables researchers to rigorously test drugs for Angelman syndrome in mice.
Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
A new protocol enables researchers to rigorously test drugs for Angelman syndrome in mice.
Researchers and autistic artists exploring virtual reality to study, treat and simulate autism traits.
A new type of speech therapy may improve the verbal abilities of children with autism who speak few or no words.
In autism research, as in other fields, small sample sizes can lead to false findings. The size of the sample needed for statistical significance depends on the type of study.
It is not a matter of whether there will be clinical trials of genetic therapy for Angelman syndrome, but when.
The accepted wisdom in autism research holds that early intervention offers the best promise for an autistic child’s well-being. But how effective are these therapies?
The U.S. Drug Enforcement Agency has made it legal for doctors to prescribe an epilepsy drug derived from marijuana. But all other compounds derived from marijuana remain under tight restrictions.
A new brain implant pumps chemical signals directly into a target region to ease seizure-like activity in mice.
Autism and post-traumatic stress disorder share many traits, but the connection between them was largely overlooked until now.
Compounds that mimic a cancer drug restore expression of the key gene mutated in Angelman syndrome, a condition related to autism.